NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-155-2006-0-PCT-02 Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties PCT PCT PCT/US2008/067059 Expired
NCI E-157-1994-1-US-20 Methods and Compositions for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations US DIV 12/140,150 Abandoned
NCI E-064-2005-0-US-06 BIOMARKERS FOR TISSUE STATUS US National Stage 11/883,535 Abandoned
NCI E-200-1990-4-JP-23 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) JP DIV 2008-156031 Abandoned
NIDDK E-235-2008-0-US-01 P2Y1 RECEPTOR ANTAGONISTS US 61/061,309 Abandoned
NIAID E-203-2008-0-US-01 MONITORING TCR-B TO DETERMINE HIV THERAPY AND DISEASE PROGRESSION US 61/131,954 Abandoned
NCI E-209-2008-0-US-01 USE OF MICRORNA-26 AS A PREDICTIVE MARKER FOR HEPATOCELLULAR CARCINOMA CLINICAL OUTCOME AND RESPONSE TO INTERFERON THERAPY US 61/131,800 Abandoned
NIAID E-240-2007-0-PCT-02 St. Louis Encephalitis Virus/Dengue Virus Type 4 Antigenic Chimeric Viruses PCT PCT PCT/US2008/066445 Expired
NIAID E-040-1999-0-US-16 Production of Attenuated Negative Stranded RNA Virus Vaccines From Cloned Nucleotide Sequences US DIV 12/136,765 Abandoned
NCI E-215-2007-0-CN-13 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN DIV 201310394618.6 Abandoned
NCI E-054-2008-0-CA-05 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith CA National Stage 2690410 Issued
NCI E-215-2007-0-FR-17 Methods for determining a hepatocellular carcinoma subtype FR EP 12179595.9 Abandoned
NCI E-215-2007-0-EP-09 Methods for determining a hepatocellular carcinoma subtype EP DIV 12179595.9 Abandoned
NCI E-215-2007-0-GB-18 Methods for determining a hepatocellular carcinoma subtype GB EP 12179595.9 Abandoned
NCI E-215-2007-0-GB-22 Methods for determining a hepatocellular carcinoma subtype GB EP 12179592.6 Abandoned
NCI E-215-2007-0-EP-10 Methods for determining a hepatocellular carcinoma subtype EP DIV 12179592.6 Abandoned
NCI E-215-2007-0-FR-21 Methods for determining a hepatocellular carcinoma subtype FR EP 12179592.6 Abandoned
NCI E-215-2007-0-ES-20 Methods for determining a hepatocellular carcinoma subtype ES EP 12179592.6 Abandoned
NCI E-215-2007-0-DE-19 Methods for determining a hepatocellular carcinoma subtype DE EP 12179592.6 Abandoned
NCI E-215-2007-0-JP-04 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells JP National Stage 2010-511218 Abandoned
NCI E-215-2007-0-IT-26 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE IT EP 08768266.2 Abandoned
NCI E-215-2007-0-FR-24 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE FR EP 08768266.2 Abandoned
NCI E-215-2007-0-ES-23 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE ES EP 08768266.2 Abandoned
NCI E-215-2007-0-EP-03 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE EP National Stage 08768266.2 Abandoned
NCI E-215-2007-0-GB-25 METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE GB EP 08768266.2 Abandoned
NCI E-054-2008-0-US-03 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith US ORD 12/135,575 8765802 Abandoned PDF
NCI E-054-2008-0-EP-06 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith EP National Stage 08768252.2 Issued
NCI E-054-2008-0-GB-07 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith GB EP 08768252.2 Issued
NCI E-054-2008-0-FR-09 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith FR EP 08768252.2 Issued
NCI E-054-2008-0-DE-08 Kinase Inhibitors, Compositions Thereof And Method of Use Therewith DE EP 08768252.2 Issued
NCI E-215-2007-0-AU-06 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells AU National Stage 2008262252 Abandoned
NCI E-054-2008-0-AU-04 Kinase Inhibitors, Composisions Thereof And Method of Use Therewith AU National Stage 2008267081 Issued
NCI E-054-2008-0-PCT-02 Kinase Inhibitors, Composisions Thereof And Method of Use Therewith PCT PCT PCT/US2008/007181 Expired
NCI E-215-2007-0-PCT-02 MicroRNA-181 Family Members Are Involved In The Function Of Liver Cancer Stem Cells Through Beta-catenin Signaling Activation PCT PCT PCT/US2008/007196 Expired
NCI E-215-2007-0-CN-16 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN DIV 201610142734.2 Abandoned
NCI E-215-2007-0-CN-08 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN National Stage 200880025276.8 Abandoned
NCI E-215-2007-0-CA-07 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CA National Stage 2690144 Abandoned
NIA E-016-2004-0-US-07 Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin US ORD 11/596,310 Abandoned
NCI E-256-2008-0-US-01 Survival Predictor For Diffuse Large B Cell Lymphoma US 61/059,678 Abandoned
NCI E-283-2000-0-JP-22 A Chimeric Protein Comprising Non-Toxic Pseudomonas Exotoxin A And Type IV Pilin Sequences JP DIV 2008-147377 Abandoned
NCI E-194-2008-0-US-01 IMMUNOTOXINS MADE WITH MODIFIED CHOLIX TOXIN AND USES THEREOF US 61/058,872 Abandoned
NCI E-194-2005-0-US-03 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE (Medusa) US National Stage 12/095,973 7871777 Abandoned PDF
NIDCR E-008-2006-0-JP-05 Single Nucleotide Polymorphisms In GCH1 For The Diagnosis And Prognosis Of Pain JP National Stage 2008-544336 Abandoned
NCI E-308-2005-0-US-04 TREATMENT OF VIRAL INFECTIONS US National Stage 12/085,895 Abandoned
NCI E-213-2007-0-PCT-02 Flexible, Polyvalent Antiviral Dendridic Conjugates for the Treatment of HIV/AIDS and Enveloped Viral Infection PCT PCT PCT/US2008/006922 Abandoned
NCI E-259-2008-0-US-01 MATERIALS AND METHODS FOR IDENTIFYING PATIENTS AT HEIGHTEN RISK FOR DEVELOPING HER2+ RELATED BRAIN TUMORS US 61/057,828 Abandoned
NHGRI E-217-2007-0-GB-22 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT GB EP 16196935.7 Issued
NHGRI E-217-2007-0-EP-14 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT EP DIV 16196935.7 Issued
NHGRI E-217-2007-0-FR-21 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT FR EP 16196935.7 Issued
NHGRI E-217-2007-0-DE-20 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT DE EP 16196935.7 Issued